Dougherty & Co Affirms 'Buy' on Uroplasty (UPI); Allergan's (AGN) Entry Is Slight Positive...Near-Term
Tweet
Share
E-mailGet Alerts UPI Hot Sheet
Price: $1.22 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Dougherty & Co affirms 'Buy' on Uroplasty (NASDAQ: UPI) price target lowered from $6.50 to $5.
Analyst, Deepak Chaulagai, said, "We think the potential entry of Allergan (NYSE: AGN) into the idiopathic market could bring further awareness to the OAB market – a slight positive for UPI. On the other hand, competition could slow UPI’s growth over the long-term. However, we think UPI has ample room to grow with a superior therapy to serve a large and underserved $3b+ OAB market. That is why we are affirming our Rating but lowering our price target (PT) to $5."
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $3.14 yesterday.
Analyst, Deepak Chaulagai, said, "We think the potential entry of Allergan (NYSE: AGN) into the idiopathic market could bring further awareness to the OAB market – a slight positive for UPI. On the other hand, competition could slow UPI’s growth over the long-term. However, we think UPI has ample room to grow with a superior therapy to serve a large and underserved $3b+ OAB market. That is why we are affirming our Rating but lowering our price target (PT) to $5."
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $3.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- DA Davidson Starts Everus (ECG) at Buy
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
